DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

Add to watchlist

$1.93 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 106 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 61.1% .

All

			Value		Shares		↓ Weighting
	Buy	DENDREON CORPnote 2.875% 1/1	$116,343,000	+5.5%	183,660,000	+3.5%	6.03%	+17.5%
AUXL	Buy	AUXILIUM PHARMACEUTICALS INC	$85,270,000	+88.3%	4,113,385	+65.3%	4.42%	+109.7%
QCOR	Buy	QUESTCOR PHARMACEUTICALS INC	$82,018,000	+504.9%	1,506,297	+544.4%	4.25%	+573.4%
CBST	Sell	CUBIST PHARMACEUTICALS INCcall	$68,870,000	-27.8%	1,000,000	-33.3%	3.57%	-19.5%
	Buy	VOLCANO CORPORATIONnote 1.750%12/0	$59,747,000	+15.7%	60,500,000	+21.0%	3.10%	+28.8%
ARRY	Buy	ARRAY BIOPHARMA INC	$56,289,000	-14.5%	11,235,406	+6.1%	2.92%	-4.8%
NXTM	Buy	NXSTAGE MEDICAL INC	$55,706,000	-15.8%	5,570,639	+10.8%	2.89%	-6.2%
INFI	Buy	INFINITY PHARMACEUTICALS INC	$54,988,000	+45.3%	3,981,743	+83.3%	2.85%	+61.8%
	Sell	NUVASIVE INCnote 2.750% 7/0	$45,559,000	-27.0%	42,136,000	-34.3%	2.36%	-18.7%
ATRS	Buy	ANTARES PHARMA INC	$45,341,000	+29.1%	10,141,174	+17.2%	2.35%	+43.8%
		INTEGRA LIFESCIENCES HLDGS Cnote 1.625%12/1	$44,486,000	+5.5%	41,523,000	0.0%	2.30%	+17.5%
HUM	New	HUMANA INC	$42,802,000	–	414,670	+100.0%	2.22%	–
		HOLOGIC INCdebt 2.000% 3/0	$38,338,000	+1.1%	37,516,000	0.0%	1.99%	+12.6%
		INTERMUNE INCnote 2.500% 9/1	$37,171,000	-0.2%	41,570,000	0.0%	1.93%	+11.2%
MRK	Buy	MERCK & CO INC NEW	$36,286,000	+60.5%	725,000	+52.6%	1.88%	+78.7%
HZNP	New	HORIZON PHARMA INC	$35,348,000	–	4,638,888	+100.0%	1.83%	–
FLML		FLAMEL TECHNOLOGIES SAsponsored adr	$34,884,000	+22.7%	4,333,475	0.0%	1.81%	+36.7%
GMED	Buy	GLOBUS MED INCcl a	$34,194,000	+63.5%	1,694,472	+41.5%	1.77%	+82.0%
CSU	Buy	CAPITAL SR LIVING CORP	$34,020,000	+53.1%	1,418,111	+35.0%	1.76%	+70.4%
UAM	Buy	UNIVERSAL AMERN CORP NEW	$33,585,000	+50.6%	4,600,692	+57.2%	1.74%	+67.8%
DVA	New	DAVITA HEALTHCARE PARTNERS I	$30,734,000	–	485,000	+100.0%	1.59%	–
	Sell	EXELIXIS INCnote 4.250% 8/1	$30,691,000	-8.9%	25,050,000	-13.6%	1.59%	+1.5%
HUM	New	HUMANA INCcall	$28,902,000	–	280,000	+100.0%	1.50%	–
TRNX	Buy	TORNIER N V	$28,372,000	+0.7%	1,509,974	+3.6%	1.47%	+12.1%
QCOR	New	QUESTCOR PHARMACEUTICALS INCcall	$27,225,000	–	500,000	+100.0%	1.41%	–
CBST	Sell	CUBIST PHARMACEUTICALS INC	$26,603,000	-24.4%	386,282	-30.3%	1.38%	-15.9%
XOMA	Sell	XOMA CORP DEL	$25,620,000	-6.4%	3,806,868	-37.6%	1.33%	+4.2%
DYAX	Sell	DYAX CORP	$25,301,000	-16.8%	3,357,747	-24.2%	1.31%	-7.3%
		ARRAY BIOPHARMA INCnote 3.000% 6/0	$23,978,000	-9.1%	23,000,000	0.0%	1.24%	+1.2%
		ACCURAY INCnote 3.750% 8/0	$23,716,000	+7.7%	21,200,000	0.0%	1.23%	+19.9%
PACB	Sell	PACIFIC BIOSCIENCES CALIF IN	$22,757,000	-15.6%	4,351,262	-10.9%	1.18%	-6.0%
AET	Sell	AETNA INC NEW	$22,429,000	-0.8%	327,000	-7.4%	1.16%	+10.6%
MOH	Buy	MOLINA HEALTHCARE INC	$22,413,000	+37.2%	644,971	+40.5%	1.16%	+52.8%
XNPT	Sell	XENOPORT INC	$21,384,000	-18.3%	3,719,040	-19.3%	1.11%	-9.0%
PTLA	Buy	PORTOLA PHARMACEUTICALS INC	$21,261,000	+565.4%	825,675	+591.2%	1.10%	+638.9%
SPPI	Sell	SPECTRUM PHARMACEUTICALS INC	$20,898,000	-17.7%	2,361,405	-22.1%	1.08%	-8.4%
MNTA	Sell	MOMENTA PHARMACEUTICALS INC	$20,096,000	-30.4%	1,136,645	-43.4%	1.04%	-22.5%
KERX	Sell	KERYX BIOPHARMACEUTICALS INC	$19,208,000	-50.5%	1,483,260	-61.5%	1.00%	-44.9%
	Sell	BROOKDALE SR LIVING INCnote 2.750% 6/1	$18,536,000	-36.6%	15,500,000	-38.0%	0.96%	-29.5%
CNC	New	CENTENE CORP DEL	$18,440,000	–	312,812	+100.0%	0.96%	–
INSM	Buy	INSMED INC	$17,888,000	+23.1%	1,052,245	+13.1%	0.93%	+37.1%
AGN	Sell	ALLERGAN INC	$16,884,000	+0.9%	152,000	-17.8%	0.88%	+12.5%
MYL	Sell	MYLAN INC	$16,579,000	-44.2%	382,000	-50.9%	0.86%	-37.8%
RNA	Sell	PROSENSA HLDG N V	$14,568,000	-31.7%	3,119,381	-3.3%	0.76%	-23.8%
	New	SEQUENOM INCnote 5.000%10/0	$14,510,000	–	16,877,000	+100.0%	0.75%	–
AIRM	Sell	AIR METHODS CORP	$14,291,000	-50.7%	245,292	-64.0%	0.74%	-45.1%
	Buy	DENDREON CORPnote 4.750% 6/1	$14,187,000	+7.4%	14,740,000	+7.3%	0.74%	+19.5%
TEVA		TEVA PHARMACEUTICAL INDS LTDcall	$14,028,000	+6.1%	350,000	0.0%	0.73%	+18.2%
PRTA	New	PROTHENA CORP PLC	$14,021,000	–	528,705	+100.0%	0.73%	–
DEPO	Sell	DEPOMED INC	$13,338,000	+18.6%	1,260,661	-16.2%	0.69%	+32.1%
IART	New	INTEGRA LIFESCIENCES HLDGS C	$12,980,000	–	272,055	+100.0%	0.67%	–
NSPH	Sell	NANOSPHERE INC	$10,870,000	+5.7%	4,746,913	-7.7%	0.56%	+17.8%
NSTG	Buy	NANOSTRING TECHNOLOGIES INC	$10,770,000	+97.1%	624,711	+25.8%	0.56%	+119.7%
BDSI	Sell	BIODELIVERY SCIENCES INTL IN	$10,371,000	-27.0%	1,760,725	-32.7%	0.54%	-18.8%
		INTERMUNE INCnote 2.500%12/1	$10,290,000	-2.1%	7,500,000	0.0%	0.53%	+9.0%
MEIP	Buy	MEI PHARMA INC	$10,049,000	+8.6%	1,254,519	+52.6%	0.52%	+21.2%
PTCT	Sell	PTC THERAPEUTICS INC	$9,249,000	-49.0%	545,027	-35.5%	0.48%	-43.2%
BLUE		BLUEBIRD BIO INC	$8,879,000	-22.2%	423,224	0.0%	0.46%	-13.4%
ZGNX	Sell	ZOGENIX INC	$8,841,000	+6.6%	2,570,000	-42.7%	0.46%	+18.7%
		ACCURAY INCnote 3.500% 2/0	$8,642,000	+14.9%	5,000,000	0.0%	0.45%	+28.0%
DSCO	Buy	DISCOVERY LABORATORIES INC N	$8,234,000	+253.7%	3,659,700	+208.1%	0.43%	+295.4%
FMI	New	FOUNDATION MEDICINE INC	$8,242,000	–	346,018	+100.0%	0.43%	–
ATEC		ALPHATEC HOLDINGS INC	$8,005,000	+2.0%	3,982,738	0.0%	0.42%	+13.7%
VNDA	Sell	VANDA PHARMACEUTICALS INC	$7,834,000	-12.8%	631,276	-23.0%	0.41%	-2.9%
AIRM		AIR METHODS CORPcall	$7,283,000	+36.9%	125,000	0.0%	0.38%	+52.6%
BAX	Buy	BAXTER INTL INC	$7,129,000	+623.8%	102,500	+583.3%	0.37%	+702.2%
ARNA		ARENA PHARMACEUTICALS INC	$7,117,000	+11.0%	1,216,579	0.0%	0.37%	+23.8%
BCRX	Sell	BIOCRYST PHARMACEUTICALS	$6,601,000	-44.5%	868,570	-46.8%	0.34%	-38.2%
MYL		MYLAN INCcall	$6,510,000	+13.7%	150,000	0.0%	0.34%	+26.7%
		ALERE INCnote 3.000% 5/1	$6,441,000	+6.4%	5,750,000	0.0%	0.33%	+18.9%
LPDX		LIPOSCIENCE INC	$5,875,000	-15.0%	1,382,350	0.0%	0.30%	-5.3%
OVAS	Sell	OVASCIENCE INC	$5,535,000	-8.1%	605,561	-0.3%	0.29%	+2.5%
CASM		CAS MED SYS INC	$5,440,000	+26.9%	3,200,000	0.0%	0.28%	+41.7%
AERI	New	AERIE PHARMACEUTICALS INC	$5,388,000	–	300,000	+100.0%	0.28%	–
ANTH		ANTHERA PHARMACEUTICALS INC	$5,194,000	-23.6%	1,691,857	0.0%	0.27%	-14.9%
CGIX	New	CANCER GENETICS INC	$4,881,000	–	354,180	+100.0%	0.25%	–
GERN	New	GERON CORP	$4,740,000	–	1,000,000	+100.0%	0.25%	–
SSH	New	SUNSHINE HEART INC	$4,195,000	–	432,000	+100.0%	0.22%	–
BINDQ	New	BIND THERAPEUTICS INC	$3,869,000	–	256,384	+100.0%	0.20%	–
CEMP	Sell	CEMPRA INC	$3,837,000	-58.5%	309,655	-61.5%	0.20%	-53.7%
LCAV		LCA-VISION INC	$2,850,000	+8.3%	730,856	0.0%	0.15%	+21.3%
		AUXILIUM PHARMACEUTICALS INCnote 1.500% 7/1	$2,771,000	+7.3%	2,500,000	0.0%	0.14%	+20.0%
INFI	New	INFINITY PHARMACEUTICALS INCcall	$2,762,000	–	200,000	+100.0%	0.14%	–
OCRX	New	OCERA THERAPEUTICS INC	$2,742,000	–	211,119	+100.0%	0.14%	–
TRGT	New	TARGACEPT INC	$2,561,000	–	617,000	+100.0%	0.13%	–
KIN	New	KINDRED BIOSCIENCES INC	$2,513,000	–	225,000	+100.0%	0.13%	–
	New	ALBANY MOLECULAR RESH INCnote 2.250%11/1	$2,407,000	–	2,575,000	+100.0%	0.12%	–
STRM	New	STREAMLINE HEALTH SOLUTIONS	$2,269,000	–	325,000	+100.0%	0.12%	–
RIGL	Sell	RIGEL PHARMACEUTICALS INC	$2,176,000	-43.1%	763,675	-28.5%	0.11%	-36.5%
NVDQ	New	NOVADAQ TECHNOLOGIES INC	$1,979,000	–	120,010	+100.0%	0.10%	–
ARWR	New	ARROWHEAD RESH CORP	$1,541,000	–	142,017	+100.0%	0.08%	–
PTN		PALATIN TECHNOLOGIES INC	$1,468,000	+6.4%	2,000,000	0.0%	0.08%	+18.8%
HMSY	New	HMS HLDGS CORP	$1,312,000	–	57,800	+100.0%	0.07%	–
ECYT	Buy	ENDOCYTE INC	$1,196,000	+78.0%	111,967	+122.0%	0.06%	+100.0%
SNSS	New	SUNESIS PHARMACEUTICALS INCcall	$1,185,000	–	250,000	+100.0%	0.06%	–
AMGN	New	AMGEN INC	$1,141,000	–	10,000	+100.0%	0.06%	–
ARTC	New	ARTHROCARE CORP	$805,000	–	20,000	+100.0%	0.04%	–
MSTX	Sell	MAST THERAPEUTICS INC	$678,000	-41.3%	1,466,249	-44.3%	0.04%	-35.2%
BIOS	Sell	BIOSCRIP INC	$518,000	-95.3%	70,022	-94.4%	0.03%	-94.7%
HCA	New	HCA HOLDINGS INC	$477,000	–	10,000	+100.0%	0.02%	–
BEAT	New	BIOTELEMETRY INC	$437,000	–	55,000	+100.0%	0.02%	–
SEM	New	SELECT MED HLDGS CORP	$341,000	–	29,400	+100.0%	0.02%	–
IMRSQ	New	IMRIS INC	$305,000	–	192,051	+100.0%	0.02%	–
BONE	Sell	BACTERIN INTL HLDGS INC	$196,000	-62.1%	391,796	-49.2%	0.01%	-58.3%
TEVA	Sell	TEVA PHARMACEUTICAL INDS LTDadr	$200,000	-99.4%	5,000	-99.4%	0.01%	-99.4%
OREX	Sell	OREXIGEN THERAPEUTICS INC	$122,000	-11.6%	21,690	-3.9%	0.01%	0.0%
ICAD	Exit	ICAD INC	$0	–	-38,887	-100.0%	-0.01%	–
BRKR	Exit	BRUKER CORP	$0	–	-21,000	-100.0%	-0.02%	–
SPHS	Exit	SOPHIRIS BIO INC	$0	–	-123,585	-100.0%	-0.03%	–
CTRX	Exit	CATAMARAN CORP	$0	–	-12,500	-100.0%	-0.03%	–
AVNR	Exit	AVANIR PHARMACEUTICALS INCcl a new	$0	–	-155,000	-100.0%	-0.03%	–
SLTM	Exit	SOLTA MED INC	$0	–	-339,063	-100.0%	-0.03%	–
GTXI	Exit	GTX INC DELcall	$0	–	-500,000	-100.0%	-0.05%	–
IRWD	Exit	IRONWOOD PHARMACEUTICALS INCput	$0	–	-100,000	-100.0%	-0.06%	–
ELN	Exit	ELAN PLCadr	$0	–	-100,000	-100.0%	-0.07%	–
HOLX	Exit	HOLOGIC INC	$0	–	-96,330	-100.0%	-0.09%	–
DNDNQ	Exit	DENDREON CORPput	$0	–	-700,000	-100.0%	-0.10%	–
	Exit	MANNKIND CORPnote 3.750%12/1	$0	–	-2,090,000	-100.0%	-0.10%	–
DRTX	Exit	DURATA THERAPEUTICS INC	$0	–	-275,979	-100.0%	-0.12%	–
SQNM	Exit	SEQUENOM INC	$0	–	-985,000	-100.0%	-0.12%	–
GEVA	Exit	SYNAGEVA BIOPHARMA CORP	$0	–	-50,000	-100.0%	-0.15%	–
NVAX	Exit	NOVAVAX INC	$0	–	-1,076,980	-100.0%	-0.16%	–
TXMD	Exit	THERAPEUTICSMD INC	$0	–	-1,250,000	-100.0%	-0.17%	–
ESRX	Exit	EXPRESS SCRIPTS HLDG CO	$0	–	-65,000	-100.0%	-0.19%	–
AGIO	Exit	AGIOS PHARMACEUTICALS INC	$0	–	-151,050	-100.0%	-0.20%	–
FRX	Exit	FOREST LABS INCcall	$0	–	-100,000	-100.0%	-0.20%	–
SRPT	Exit	SAREPTA THERAPEUTICS INCput	$0	–	-100,000	-100.0%	-0.22%	–
CCRN	Exit	CROSS CTRY HEALTHCARE INC	$0	–	-1,343,464	-100.0%	-0.38%	–
EW	Exit	EDWARDS LIFESCIENCES CORPcall	$0	–	-200,000	-100.0%	-0.65%	–
CAH	Exit	CARDINAL HEALTH INC	$0	–	-325,000	-100.0%	-0.79%	–
PCYC	Exit	PHARMACYCLICS INC	$0	–	-127,030	-100.0%	-0.82%	–
SGNT	Exit	SAGENT PHARMACEUTICALS INC	$0	–	-1,014,863	-100.0%	-0.96%	–
ARIA	Exit	ARIAD PHARMACEUTICALS INC	$0	–	-1,227,204	-100.0%	-1.05%	–
ALNY	Exit	ALNYLAM PHARMACEUTICALS INC	$0	–	-383,158	-100.0%	-1.14%	–
ONTX	Exit	ONCONOVA THERAPEUTICS INC	$0	–	-967,696	-100.0%	-1.19%	–
ANGO	Exit	ANGIODYNAMICS INC	$0	–	-2,013,104	-100.0%	-1.24%	–
AGN	Exit	ALLERGAN INCcall	$0	–	-300,000	-100.0%	-1.26%	–
CYH	Exit	COMMUNITY HEALTH SYS INC NEW	$0	–	-711,738	-100.0%	-1.37%	–
FRX	Exit	FOREST LABS INC	$0	–	-745,000	-100.0%	-1.48%	–
THC	Exit	TENET HEALTHCARE CORP	$0	–	-788,000	-100.0%	-1.51%	–
THOR	Exit	THORATEC CORP	$0	–	-891,000	-100.0%	-1.54%	–
ABBV	Exit	ABBVIE INC	$0	–	-1,005,000	-100.0%	-2.09%	–
AZN	Exit	ASTRAZENECA PLCsponsored adr	$0	–	-928,000	-100.0%	-2.24%	–
PFE	Exit	PFIZER INC	$0	–	-1,805,000	-100.0%	-2.41%	–

Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Flynn Management LLC #1

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2014-02-14

Signatures

The EDGAR filing(s) were signed by:

Flynn Management LLC, its general partner James E. Flynn — Managing Member

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
AERIE PHARMACEUTICALS INC	36	Q3 2022	3.6%
CENTENE CORP DEL	30	Q3 2023	3.0%
BIOCRYST PHARMACEUTICALS INC	29	Q3 2023	2.2%
MOLINA HEALTHCARE INC	26	Q3 2022	1.7%
EHEALTH INC	25	Q3 2020	2.0%
INTERCEPT PHARMACEUTICALS IN	24	Q1 2023	2.2%
MYLAN NV	23	Q3 2020	6.2%
PORTOLA PHARMACEUTICALS INC	23	Q1 2019	6.0%
BROOKDALE SR LIVING INC	23	Q3 2023	2.2%
ALIMERA SCIENCES INC	23	Q3 2019	0.8%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.

Latest significant ownerships (13-D/G)

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Q4 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
DA32 Life Science Tech Acquisition Corp.	August 01, 2023	5,145,000	91.1%
CareMax, Inc.	March 13, 2023	18,691,423	16.4%
CareMax, Inc.	June 02, 2022	18,691,423	20.7%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.

Latest filings

Type	Filed
3	2024-03-19
4	2024-03-19
4	2024-03-12
3	2024-03-08
4	2024-02-16
13F-HR	2024-02-14
4	2024-02-08
3	2024-02-01
4	2023-11-21
13F-HR	2023-11-14

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

The reported total value is incorrect (1930351000.0 != 1930346000.0)

Export DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s holdings

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - Q4 2013 holdings